Integrated Investment Consultants, LLC Invitae Corp Transaction History

Integrated Investment Consultants, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$26.09 - $40.4 $370,086 - $573,074	-14,185 Closed	0 $0
Q1 2021 Apr 20, 2021	BUY	$33.06 - $56.93 $136,207 - $234,551	4,120 Added 40.93%	14,185 $542,000
Q4 2020 Feb 09, 2021	BUY	$39.09 - $57.4 $6,645 - $9,758	170 Added 1.72%	10,065 $421,000
Q3 2020 Oct 26, 2020	SELL	$28.43 - $44.67 $10,092 - $15,857	-355 Reduced 3.46%	9,895 $429,000
Q2 2020 Aug 04, 2020	BUY	$11.71 - $30.29 $120,027 - $310,472	10,250 New	10,250 $310,000
Q1 2020 May 22, 2020	SELL	$7.64 - $27.5 $1.22 Million - $4.4 Million	-159,830 Closed	0 $0
Q4 2019 Jan 29, 2020	BUY	$15.02 - $20.57 $1.28 Million - $1.76 Million	85,370 Added 114.65%	159,830 $2.58 Million
Q3 2019 Oct 21, 2019	BUY	$18.85 - $27.5 $1.4 Million - $2.05 Million	74,460 New	74,460 $1.44 Million

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Integrated Investment Consultants, LLC, based on Form 13F filings with the SEC.

Stay updated on Integrated Investment Consultants, LLC with notifications on news.